Department of Statistics, West Virginia University, Morgantown, WV 26506, USA.
BMC Cancer. 2010 Jul 1;10:346. doi: 10.1186/1471-2407-10-346.
Aneuploidy has long been recognized to be associated with cancer. A growing body of evidence suggests that tumorigenesis, the formation of new tumors, can be attributed to some extent to errors occurring at the mitotic checkpoint, a major cell cycle control mechanism that acts to prevent chromosome missegregation. However, so far no statistical model has been available quantify the role aneuploidy plays in determining cancer.
We develop a statistical model for testing the association between aneuploidy loci and cancer risk in a genome-wide association study. The model incorporates quantitative genetic principles into a mixture-model framework in which various genetic effects, including additive, dominant, imprinting, and their interactions, are estimated by implementing the EM algorithm.
Under the new model, a series of hypotheses tests are formulated to explain the pattern of the genetic control of cancer through aneuploid loci. Simulation studies were performed to investigate the statistical behavior of the model.
The model will provide a tool for estimating the effects of genetic loci on aneuploidy abnormality in genome-wide studies of cancer cells.
非整倍体长期以来一直被认为与癌症有关。越来越多的证据表明,肿瘤发生,即新肿瘤的形成,在某种程度上可以归因于有丝分裂检查点(mitotic checkpoint)出现的错误。有丝分裂检查点是一种主要的细胞周期控制机制,用于防止染色体错误分离。然而,到目前为止,还没有统计模型可以定量确定非整倍体在决定癌症中的作用。
我们开发了一种统计模型,用于在全基因组关联研究中测试非整倍体基因座与癌症风险之间的关联。该模型将定量遗传原理纳入混合模型框架中,通过实施 EM 算法来估计各种遗传效应,包括加性、显性、印迹及其相互作用。
在新模型下,通过非整倍体基因座,制定了一系列假设检验来解释癌症遗传控制的模式。进行了模拟研究以研究模型的统计行为。
该模型将为估计遗传基因座对癌症细胞全基因组研究中非整倍体异常的影响提供工具。